People
BiondVax Pharmaceuticals names new director
29 December 2021 -

BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), an Israel-based biopharmaceutical company, announced on Monday that it has named Jay Green as its new director.

Green has completed a six-year term as senior vice president Finance and CFO of GlaxoSmithKline plc's (NYSE: GSK) global vaccines business.

BiondVax also announced the retirement of Isaac Devash from the board of directors.

Login
Username:

Password: